{"id":9469,"date":"2026-01-07T12:48:11","date_gmt":"2026-01-07T09:48:11","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9469"},"modified":"2026-01-07T12:50:46","modified_gmt":"2026-01-07T09:50:46","slug":"when-bp-is-180-80-which-drug-best-targets-systolic-hypertension","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/when-bp-is-180-80-which-drug-best-targets-systolic-hypertension\/","title":{"rendered":"When BP Is 180\/80: Which Drug Best Targets Systolic Hypertension?"},"content":{"rendered":"<div>When BP Is 180\/80: Which Drug Best Targets Systolic Hypertension?<\/div>\n<div><\/div>\n<div>Short Answer<\/div>\n<div><\/div>\n<div>Thiazide-like diuretics provide the greatest and most consistent reduction in systolic blood pressure (SBP) and remain the most widely used first-line agents, particularly in isolated systolic hypertension.<\/div>\n<div><\/div>\n<div>Why Thiazide-Like Diuretics Lead<\/div>\n<div><span> \u2022 Chlorthalidone and indapamide achieve the strongest SBP reduction<\/span><\/div>\n<div><span> \u2022 Best evidence in isolated systolic hypertension<\/span><\/div>\n<div><span> \u2022 Proven reduction in stroke and cardiovascular events<\/span><\/div>\n<div><span> \u2022 Recommended as first-line therapy across major guidelines<\/span><\/div>\n<div><\/div>\n<div>How Other Agents Compare<\/div>\n<div><span> \u2022 Calcium Channel Blockers (CCBs) (e.g., amlodipine)<\/span><\/div>\n<div><span> \u2022 Highly effective for systolic BP<\/span><\/div>\n<div><span> \u2022 Especially beneficial in older adults<\/span><\/div>\n<div><span> \u2022 ACE inhibitors \/ ARBs<\/span><\/div>\n<div><span> \u2022 Moderate SBP reduction<\/span><\/div>\n<div><span> \u2022 Preferred when comorbidities are present (diabetes, CKD, heart failure)<\/span><\/div>\n<div><\/div>\n<div>Guideline Perspective<\/div>\n<div><span> \u2022 Consensus trends (AHA\/ACC 2025, ESC 2024, BIHS 2025):<\/span><\/div>\n<div><span> \u2022 Intensive control: near-universal target &lt;130\/80 mmHg<\/span><\/div>\n<div><span> \u2022 Risk-based treatment: focus on 10- and 30-year risk (e.g., PREVENT)<\/span><\/div>\n<div><span> \u2022 Mandatory testing: routine urine ACR for early kidney damage<\/span><\/div>\n<div><\/div>\n<div>Clinical Takeaway<\/div>\n<div>Thiazide-like diuretics are the most effective and most commonly used drugs for lowering systolic BP, followed closely by long-acting calcium channel blockers.<\/div>\n<div><\/div>\n<div>Sources-Guideline Background<\/div>\n<div><span> \u2022 ESH Clinical Practice Guidelines 2024<\/span><\/div>\n<div><span> \u2022 ESC Guidelines 2024\u00a0<\/span><\/div>\n<div><a href=\"https:\/\/www.eshonline.org\/guidelines\/2023-guidelines\/?utm_source=chatgpt.com\">https:\/\/www.eshonline.org\/guidelines\/2023-guidelines\/?utm_source=chatgpt.com<\/a><\/div>\n<div><\/div>\n<div><span> \u2022 ISH \u2013 complements ESH\/ ESC2024 \/ACC-AHA 2025 with global applicability<\/span><\/div>\n<div><\/div>\n<div>\n<div>Key Links<\/div>\n<div><span> \u2022 ESH 2023\/2024-concise update :<\/span><\/div>\n<div><a href=\"https:\/\/www.eshonline.org\/guidelines\/2023-guidelines\/\">https:\/\/www.eshonline.org\/guidelines\/2023-guidelines\/<\/a><\/div>\n<div><\/div>\n<div><span> \u2022 AHA\/ACC 2025<\/span><\/div>\n<div><a href=\"https:\/\/www.ahajournals.org\/guidelines\/high-blood-pressure\">https:\/\/www.ahajournals.org\/guidelines\/high-blood-pressure<\/a><\/div>\n<div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>When BP Is 180\/80: Which Drug Best Targets Systolic Hypertension? Short Answer Thiazide-like diuretics provide the greatest and most consistent reduction in systolic blood pressure (SBP) and remain the most widely used first-line agents, particularly in isolated systolic hypertension. Why Thiazide-Like Diuretics Lead \u2022 Chlorthalidone and indapamide achieve the strongest SBP reduction \u2022 Best evidence [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9469","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9469"}],"version-history":[{"count":3,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9469\/revisions"}],"predecessor-version":[{"id":9475,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9469\/revisions\/9475"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}